Uterine Cancer Study Act of 2025

# Uterine Cancer Study Act of 2025 — Plain Language Summary **What the Bill Would Do** The Uterine Cancer Study Act of 2025 would authorize a comprehensive research study on uterine cancer. If passed, this legislation would direct resources toward better understanding the disease, including its causes, risk factors, prevalence, and outcomes across different populations. The bill aims to fill knowledge gaps about uterine cancer to improve prevention, detection, and treatment options. **Who It Affects** This bill primarily affects women diagnosed with or at risk for uterine cancer, as well as medical researchers and healthcare providers who treat the disease.

It would also impact federal health agencies responsible for conducting or overseeing the study, such as the National Institutes of Health or the Centers for Disease Control and Prevention. **Current Status** As of now, the bill remains in committee review, meaning it has been introduced but has not yet been debated or voted on by the full Senate. The bill was sponsored by Senator Lisa Blunt Rochester, a Democrat from Delaware.